Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GMAB) Equity Average (2024 - 2025)

Historic Equity Average for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $5.8 billion.

  • Genmab A's Equity Average rose 1679.76% to $5.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.8 billion, marking a year-over-year increase of 1679.76%. This contributed to the annual value of $5.5 billion for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Genmab A's Equity Average is $5.8 billion, which was up 1679.76% from $5.5 billion recorded in Q3 2025.
  • In the past 5 years, Genmab A's Equity Average ranged from a high of $5.8 billion in Q4 2025 and a low of $4.6 billion during Q3 2024